Therapeutic strategies for congenital myasthenic syndromes

To date, more than 25 genes have been implicated in the etiology of the congenital myasthenic syndromes (CMS), and an ever-growing phenotypic landscape is now encountered in the CMS clinic. Unlike the autoimmune form of myasthenia, there is no role for immunomodulatory agents in the treatment of CMS...

詳細記述

書誌詳細
主要な著者: Lee, M, Beeson, D, Palace, J
フォーマット: Journal article
言語:English
出版事項: Wiley 2018